| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 15:23 | Eurohold Bulgaria AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 | ||
| 14:23 | Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 | ||
| 13:23 | Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 | ||
| 13:23 | Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 | ||
| 11:23 | Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 | ||
| 09:22 | Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 | ||
| Mo | Sirma Group Holding AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 | ||
| Mo | Eurohold Bulgaria AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 | ||
| Mo | Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 | ||
| Mo | Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 | ||
| Mo | Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 | ||
| Mo | Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 | ||
| Fr | Bulgarian Real Estate Fund REIT: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 | ||
| Fr | Eurohold Bulgaria AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 | ||
| Fr | Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 | ||
| Fr | Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 | ||
| Fr | Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 | ||
| Fr | Tchaikapharma High Quality Medicines AD: Consolidated quarterly financial report | ||
| Fr | Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 | ||
| Fr | Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 | ||
| Do | Eurohold Bulgaria AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 | ||
| Do | MFG Invest AD: Other unregulated information | ||
| Do | Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 | ||
| Do | Wiser Technology AD: Other unregulated information | ||
| Do | Eurohold Bulgaria AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 |